✦ LIBER ✦

Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group

✍ Scribed by Lorenzo Gianni; Bernard F. Cole; Ilaria Panzini; Raymond Snyder; Stig B. Holmberg; Michael Byrne; Diana Crivellari; Marco Colleoni; Stefan Aebi; Edda Simoncini; Olivia Pagani; Monica Castiglione-Gertsch; Karen N. Price; Aron Goldhirsch; Alan S. Coates; Alberto Ravaioli

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 165 KB
Volume: 16
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-007-0295-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ocular toxicity during adjuvant chemoend

Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer : Results from International Breast Cancer Study Group Trials

✍ Lorenzo Gianni; Ilaria Panzini; Sigui Li; Richard D. Gelber; John Collins; Stig 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Prognostic and predictive impact of cent

Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer: Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy

✍ Eugenio Maiorano; Meredith M. Regan; Giuseppe Viale; Mauro G. Mastropasqua; Marc 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 290 KB

Is adjuvant chemotherapy of benefit for

Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12–93

✍ Olivia Pagani; Shari Gelber; Edda Simoncini; Monica Castiglione-Gertsch; Karen N 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 281 KB

Feasibility of two dose-dense FEC regime

Feasibility of two dose-dense FEC regimens with growth factor support for adjuvant therapy in patients with early breast cancer: results from a randomised study of the Central European Cooperative Oncology Group (CECOG)

✍ Zsuzsanna Kahán; Stanislav Spanik; Maria Wagnerova; Tomas Skacel; Barbara Planko 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 208 KB

Decreased immunoreactivity for p27 prote

Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status : Results from International Breast Cancer Study Group Trial V

✍ Vito J. Spataro; Heather Litman; Giuseppe Viale; Fausto Maffini; Michele Masullo 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to clarify the prognostic and predictive value of immunoreactivity for the cyclin‐dependent kinase inhibitor p27(Kip1) in patients with early‐stage breast carcinoma and to investigate its relation with clinicopathologic features and other m

Granulocyte-colony stimulating factor in

Granulocyte-colony stimulating factor in the prevention of postoperative infectious complications and sub-optimal recovery from operation in patients with colorectal cancer and increased preoperative risk (ASA 3 and 4)¶ Protocol for a controlled clinical trial developed by consensus of an international study group¶ Part two: design of the study

✍ A. Bauhofer; W. Lorenz; B. Stinner; M. Rothmund; M. Koller; H. Sitter; I. Celik; 📂 Article 📅 2001 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 242 KB